Symposium on Advances in Multiple Myeloma
The following abstracts represent the presentations given at IWWM-9 (Amsterdam-2016), Multiple Myeloma Symposium:
Session Chairs: Pieter Sonneveld (Netherlands) and Kenneth Anderson (USA)
How can we use genomic sequencing to understand therapy related clonal evolution in multiple myeloma? N. Munshi (USA)
What are the lessons learned for evaluating depth of response in myeloma? O. Landgren (USA)
Should carfilzomib or ixazomib represent the new standard for proteasome inhibitor therapy in myeloma? P. Sonneveld (Netherlands)
Where do monoclonal antibodies fit into the treatment strategy for myeloma? M. Dimopoulos (Greece)
How can we improve monoclonal antibody efficacy in myeloma? N. van de Donk (Netherlands)
Do we still need autologous transplants in the era of novel therapeutics? B. Barlogie (USA)
Does myeloma have an Achilles heel? K. Anderson (USA)